 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Medicine > Osteotech, Inc.
 |
Osteotech, Inc. |
 |
 |
 |
PROFILE |
 |
Osteotech makes no bones about its business -- well, yes, it does. The company uses donated tissue from deceased humans to make bone products for the orthopedic, neurological, oral/maxillofacial, dental, and general surgery markets in the US and Europe. Its Grafton Demineralized Bone Matrix (60% of sales) can induce bones to grow. The firm also produces bone connective tissue used in spinal fusion procedures. In addition, Osteotech offers ceramic products used as bone graft substitutes, distributes metal spinal implant products, and processes bovine tissue used in bone grafts. The American Red Cross and the Musculoskeletal Transplant Foundation account for 90% of the company's revenue.
COMPETITION |
 |
Interpore International, Inc. (BONZ)
OrthoLogic Corp. (OLGC)
Orthofix International N.V. (OFIX)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 75.70
1-Yr. Sales Growth: 0.1%
Employees: 350
Revenue per employee: $216,285.71
KEY PEOPLE |
 |
Richard W. Bauer
CEO
Michael J. Jeffries
CFO
CONTACT INFO |
 |
51 James Way
Eatontown, NJ 07724
US
Phone: 732-542-2800
Fax: 732-542-9312
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |